Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank7
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-38.53M
↓ 61% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
$-23.86M
Historical baseline
PeriodValueYoY Change
2025$-38.53M+8.3%
2024$-42.00M-14.3%
2023$-36.73M-10.3%
2022$-33.32M-41.6%
2021$-23.53M-32.9%
2020$-17.71M-13.5%
2019$-15.60M-13.1%
2018$-13.79M-38.1%
2017$-9.99M-34.1%
2016$-7.45M-